AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06480474 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Deprexis
Description: The internet-based self-help program used in this study, Deprexis, contains 10 modules ( based on different psychotherapeutic approaches, consistent with a cognitive-behavioral perspective) and accessible at any time via regular internet browsers on laptops, computers, tablets, or smartphones through a secure website. Participants can repeat all modules as often as they wish after completing the full sequence once.
Study NCT06480474 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Deprexis with online forum
Description: Those in this group will have access to deprexis ( same as the first group) as well as an online forum built for the study. This forum will feature a general discussion page where participants can ask and answer questions, and they will be divided into groups of 10 to share experiences if they wish. Additionally, there will be subforums related to specific modules of the program. Participants can share their experiences and ask questions related to the modules. A moderator will regularly check to ensure no personal or sensitive information is disclosed and will ask questions weekly to encourage contributions to the forum.
Study NCT05938816 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Description: MBSR consists of weekly two-hour sessions for eight weeks, and a 7.5 hour retreat between weeks 6 and 7. The MBSR intervention will be facilitated by an experienced and certified MBSR teacher. MBSR curriculum strongly encourages completion of home practice assignments (\~30 minutes daily) to help integration of concepts into daily life. Participants will receive audio CDs and a DVD to help guide home practice.
Study NCT05938816 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Health and Wellness Education (HWE)
Description: HWE is a didactic-based group intervention designed as an active comparator for randomized-controlled trials of MBSR. HWE provides instruction to participants regarding improving their emotional and physical health. In contrast to MBSR, there are no attempts to train participants' breathing, movement, or meditation habits or practices. HWE is administered in 8 weekly 2.5-hour classes with home practice to be completed between sessions (matched to MBSR for amount and effort). HWE also features one extended 7.5-hour retreat, similar to MBSR.84 Dr. Autumn Gallegos (consultant) has conducted trials of MBSR among veterans with PTSD using a HWE control group, and will provide mentorship to the PI in administering the HWE intervention. Dr. Kaplan and a trained RA will facilitate HWE.
Study NCT05512364 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elacestrant
Description: 400mg QD orally on a continuous dosing schedule
Study NCT05512364 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tamoxifen
Description: 20 mg QD orally on a continuous dosing schedule
Study NCT05512364 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Letrozole 2.5mg
Description: 2.5 mg QD orally on a continuous dosing schedule
Study NCT05512364 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anastrozole 1mg
Description: 1 mg QD orally on a continuous dosing schedule
Study NCT05512364 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Exemestane 25 MG
Description: 25 mg QD orally on a continuous dosing schedule
Study NCT05032430 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CCC
Description: A mix of mindfulness-based stress reduction, mindful eating, and mindful parenting strategies.
Study NCT05032430 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Usual Care
Description: Consists of strategies meant to enhance health and well-being (e.g., health education, strategies to get more physical activity) but does not include mindfulness as an active ingredient.
Study NCT04807569 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peripheral magnetic neuromodulation
Description: Non-invasive peripheral magnetic neuromodulation using the BTL Emsella magnetic stimulator according to the manufacturer's standard protocol: pelvic floor rehabilitation
Study NCT04807569 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Taking drug Tamsulosin
Description: Tamsulosin at a dose of 0.4 mg x 1 time per day orally for 1 month.
Study NCT06139380 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ketamine
Description: This is medication which is commonly used for sedation in the emergency department. At the analgesic dose, this medication can be used to reduce the pain via other routes such as intranasal.
Study NCT06139380 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Sterile water
Description: Intranasal sterile water was administered via syringe.
Study NCT05938881 — intervention group
Intervention type: PROCEDURE
Intervention: self-cut mesh procedure
Description: transvaginal mesh procedure using self-cut mesh
Study NCT05938881 — intervention group
Intervention type: PROCEDURE
Intervention: mesh-kit procedure
Description: transvaginal mesh procedure using mesh-kit
Study NCT05325138 — intervention group
Intervention type: OTHER
Intervention: Interview
Description: Parents of girls aged 9-14yearsold will undergo an interview to determine their knowledge, attitudes and beliefs concerning HPV vaccination
Study NCT05327478 — intervention group
Intervention type: PROCEDURE
Intervention: NRP
Description: Normothermic Regional Perfusion
Study NCT05327478 — intervention group
Intervention type: PROCEDURE
Intervention: DHOPE
Description: Dual Hypothermic Oxygenated Perfusion
Study NCT05327478 — intervention group
Intervention type: PROCEDURE
Intervention: COR-NMP
Description: Controlled Oxygenated Rewarming Normothermic Machine Perfusion
Study NCT04918940 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Determination of COVID-19 vacciantion efficacy
Description: Samples will be taken after each vaccine injection to perform Sars-Cov-2 serology and Elispot interferon gamma and 3 months after the first vaccine injection
Study NCT06338865 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Carbon dioxide
Description: Gas used for insufflation pressure
Study NCT06338865 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Carbon dioxide
Description: Gas used for insufflation pressure
Study NCT06338865 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine
Description: Local subcutaneous infiltration of all port sites with 0.25% bupivacaine will be performed prior to each incision. Remaining local anesthetic will be administered into the incision sites prior to the conclusion of the case (30cc total).
Study NCT06338865 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine
Description: Local subcutaneous infiltration of all port sites with 0.25% bupivacaine will be performed prior to each incision. Remaining local anesthetic will be administered into the incision sites prior to the conclusion of the case (30cc total).
Study NCT06338865 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxycodone
Description: All patients will be prescribed a total of 10 pills of oxycodone 5mg, which is the standard amount that our practice prescribes for patients after laparoscopic surgery.
Study NCT06338865 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxycodone
Description: All patients will be prescribed a total of 10 pills of oxycodone 5mg, which is the standard amount that our practice prescribes for patients after laparoscopic surgery.
Study NCT05466448 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RZL-012
Description: concentration of injected formulation 50 mg/mL RZL-012 of 7.5 mg/0.15 mL/injection point that results in a maximum total dose/volume of 240±30 mg/4.8±0.6 mL RZL-012
Study NCT04713358 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nalmefene
Description: Immediately Intravenous injection of Nalmefene (0.25 g/kg, plus normal saline to 1ml) after surgery
Study NCT04713358 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal Saline
Description: Immediately Intravenous injection of normal saline 1ml after surgery
Study NCT06430749 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Microtaze
Description: Targeted Microwave Tissue Coagulation
Study NCT04992832 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: human umbilical cord mesenchymal stem cells
Description: Human umbilical cord mesenchymal stem cells were peripheral intravenous infused to experimental group.
Study NCT04992832 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: human serum albumin
Description: Saline solution containing 1 percent human serum albumin will be infused to the control group.
Study NCT05255562 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Combined Serratus Anterior Plane Block
Description: Combined deep and superficial serratus anterior plane block will be applied to the patients under real-time ultrasound guidance.
Study NCT05255562 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Thoracic Paravertebral Block
Description: Thoracic paravertebral block will be applied to the patients under real-time ultrasound guidance.
Study NCT05182229 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home-based (a hybrid model) CDT
Description: Participants will be provided therapist-administered, in person complete decongestive therapy (CDT) two times per week for two weeks (4 sessions), followed by real-time, virtual CDT consultations two times per week for three weeks (7 sessions) and one in person follow-up visit.
Study NCT05182229 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clinic-based CDT
Description: Participants will be provided therapist administered, in-person CDT two times per week for six weeks (12 sessions).
Study NCT05669248 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: mid covid-19 patients
Description: Collect the patient's whole blood for testing
Study NCT05458232 — intervention group
Intervention type: DRUG
Intervention: Tadalafil 5mg
Description: Subjects will ingest one 5mg tablet of tadalafil each evening for 14 days.
Study NCT04953637 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Description: Participants in the physiotherapy group will receive gait and balance focused physiotherapy at One Step Ahead Mobility physiotherapy clinic for 1-hour per day, 3 times/week for 8 weeks.
Study NCT05983367 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ompenaclid
Description: Ompenaclid (RGX-202-01)
Study NCT05983367 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05983367 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Bevacizumab
Study NCT05983367 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Bevacizumab
Description: Bevacizumab
Study NCT05983367 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLFIRI regimen
Description: FOLFIRI regimen (irinotecan 180 mg/m2 over 90 minutes concurrently with folinic acid 400 mg/m2 over 2 hours, and then 5-FU 2400 mg/m2 over 46 hours on Days 1 and 15 of each 28-day cycle)
Study NCT05983367 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: FOLFIRI regimen
Description: FOLFIRI regimen (irinotecan 180 mg/m2 over 90 minutes concurrently with folinic acid 400 mg/m2 over 2 hours, and then 5-FU 2400 mg/m2 over 46 hours on Days 1 and 15 of each 28-day cycle)
Study NCT05361018 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Whole Body Vibration exercise - WBV
Description: participants will be randomised to two different training interventions
Study NCT05361018 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Whole Body Vibration exercise - WBV
Description: participants will be randomised to two different training interventions
Study NCT05895175 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: Questionnaires
Study NCT05801523 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: laparoscopic ethanol sclerotherapy
Description: ethanol (96%) sclerapy of endometrioma - endometrioma is filled with ethanol via foley catether, left for 10 min and than aspirated, endometrioma is washed with saline
Study NCT05801523 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: laparoscopic cystectomy of endometrioma
Description: cystectomy of endometrioma - removal of endometrioma from ovary surgically
Study NCT04766424 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep extension intervention
Description: Participants will receive a fitbit and 8 weekly sleep-related educational materials via email and telephone coaching to review their sleep tracker data, set goals, trouble shoot any problems, and increase motivation.
Study NCT04766424 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Health education
Description: Participants will receive 8 weekly health education newsletters delivered via email.
Study NCT06478199 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: semen analysis
Description: lab invesigation
Study NCT06407479 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: proprioceptive neuromuscular facilitation technique group
Description: Proprioceptive Neuromuscular Facilitation Technique group; In addition to the exercises applied to the participants and the control group, combined isotonic contractions and dynamic stabilization will be used as facilitation techniques, and hold-relax technique will be used as an inhibition technique.
Study NCT06407479 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: eccentric muscle training technique application group
Description: Eccentric Muscle Training Technique: Participants will receive eccentric muscle training in addition to the exercises given to the control group. Before the application, 5-minute warm-up exercises will be given to the neck area. Eccentric muscle training will be applied to the muscles of the participants in the cervical region. Eccentric exercise will be strengthened in the cervical region muscles in the direction of movement in each plane, that is, flexion / extension and lateral flexion. The movements will first be explained and demonstrated to the patient.
Study NCT06407479 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: No intervention will be made.
Study NCT05474651 — intervention group
Intervention type: OTHER
Intervention: Questionnaires set
Description: Participants will be asked to respond to the demographic information sheet, characteristics of smoking sheet, the Fagerstrom Test of Nicotine Dependence,Smoking Self-efficacy Questionnaire, Cigarette Withdrawal Scale, smoking hazard questionnaire, motivation to quit smoking sheet, ability to quit smoking sheet, alcohol consumption, International Physical Activity Questionnaire.
Study NCT06255210 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine+Cisplatin(GP); Cyclophosphamide+Etoposide+Cisplatin(CEP)
Description: When the Ki67% index of the tumor is ≥ 25%, patients were treated with the GP regimen for induction chemotherapy; When the Ki67% index of the tumor is \< 25%, patients were treated with the CEP regimen for induction chemotherapy.
Study NCT05065671 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tolcapone 100 MG
Description: Tolcapone 100 mg by mouth once
Study NCT05065671 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Duloxetine 20 MG
Description: Duloxetine 20 mg by mouth once
Study NCT05734807 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nucleoside/nucleotide reverse transcriptase inhibitors (NrtIs)
Description: Subjects will receive NrtIs therapy for 24 weeks.
Study NCT05734807 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HH-003 and NrtIs
Description: Subjects will receive HH-003 20 mg/kg intravenously Q2W and NrtIs therapy for 24 weeks.
Study NCT05734807 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HH-003, NrtIs and PEG-IFN-α
Description: Subjects will receive HH-003 20 mg/kg intravenously Q2W, NrtIs therapy and PEG-IFN-α 180μg SC QW for 24 weeks.
Study NCT05168566 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sutetinib Maleate Capsule
Description: Study drug to be taken orally with or without food (with food preferred) for up to13 cycles
Study NCT05594589 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lemborexant
Description: Lemborexant oral tablet.
Study NCT05594589 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: PBO
Description: Lemborexant-matched PBO tablet.
Study NCT05212935 — intervention group
Intervention type: BIOLOGICAL
Intervention: Rotavirus Vaccine
Description: administration of the 3 doses of Rotavirus human bovine pentavalent reassortant vaccine
Study NCT05334511 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional Electrical Stimulation
Description: functional electrical stimulation with Frequency 20 pps with Pulse width of 300 msec.
Study NCT05603663 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Informing study subjects about their high CVD polygenic risk score
Description: During a visit, the family physician will announce the value of the subject's polygenic risk for CVD (either at the start or end of the trial, depending on the group) and discuss what it means, calculate the subject's overall risk for CVD using the Kardiokompass tool, advise the subject on weight loss and physical activity, and, if necessary, commence preventive treatment. Between visits, a mobile application will be utilized to collect data about the subjects' level of physical activity and body weight as well as to send reminders to the subjects every two weeks regarding exercise and healthy lifestyle choices.
Study NCT06336759 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Restylane Defyne
Description: Twenty (20) subjects with thin skin will be recruited and treated with Restylane Defyne.
Study NCT06336759 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Restylane Lyft
Description: Twenty (20) subjects with thick skin will be recruited and treated with Restylane Lyft.
Study NCT05904990 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: traditional exercise therapy only
Description: 50-minute program included a 10-minute warm-up phase (treadmill walking at a comfortable speed), 30 minutes of stretching exercises for (glutei, paraspinal muscles, hamstring, pectoralis, scalenus, intercostal muscles, and trapezius), and a 10-minute cool-down involving self-stretching and respiratory exercises
Study NCT05904990 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HILT alongside traditional exercise therapy
Description: YAG laser device (HIRO 3.0; ASA Laser, Arcugnano, Italy). This equipment delivers pulsed laser light at a wavelength of 1,064 nm, with a very high peak power of 3 kW and energy density ranging from 360 to 1,780 mJ/cm2. It operates with short pulse durations between 120 and 150 μs, at low frequencies of 10 to 40 Hz, and has a duty cycle of about 0.1%.
Study NCT05704491 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: artificial intelligence (AI) algorithm of the MONA DR model
Description: A 45-degree fundus image is taken for each eye and patient using the Crystalvue NFC 600. The fundus photographs are then analyzed using the MONA DR model and classified for presence of diabetic retinopathy.
Study NCT05070754 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Floating electrode-dielectric barrier device (FE-DBD) cold atmospheric plasma (CAP)
Description: The treatment device in this study generates cold atmospheric plasma. Cold atmospheric plasma has certain properties of plasma, such as ionized gas molecules. To create plasma, a pulse generator supplying 20 kilovolt pulse of 20-ns pulse width at 200 Hz (FPG10-01NM10, FID GmbH, Burbach, Germany) to a 5-mm diameter quartz-covered copper electrode of 10-cm length and 1 - 13mm quartz thickness. These nanosecond pulse parameters were chosen to provide sufficient treatment dose at the high level of plasma uniformity required to avoid any tissue damage. We will treat the lesions for approximately 1 to 2 minutes each, moving the electrode gently over the treatment area.
Study NCT05070754 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cryotherapy
Description: Cryotherapy refers to the application of liquid nitrogen using a cryospray device in order to freeze a lesion of interest. Treatment is repeated every few weeks until the lesion of interest has disappeared. It is considered SOC for the treatment of warts.
Study NCT05070754 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Canthardin Collodion
Description: Chemical compound that acts as a vesicant to form a blister around treatment area. The blister lifts the lesion of interest away from the skin, causing it to slough off in a few days. It is used as SOC for the treatment of Molluscum Contagiosum.
Study NCT05856747 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TBP-PI-HBr
Description: TBP-PI-HBr tablets.
Study NCT06468046 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mama Empoderada [Mom Power]
Description: 'Mamá Empoderada' \[Mom Power\] is a theory-based, trauma-informed group intervention to promote mental health and positive parenting among mothers with young children (0-5 years). It has been adapted for migrant mothers, and will conduct a pilot randomized controlled trial (RCT) of the intervention with migrant mothers with young children (MMC). The intervention group (IG) will receive 10 group and 3 individual sessions addressing attachment theory, hands-on parenting skills, linkage to resources (e.g., food, shelter), social support, and self-care and resilience.